Monoclonal antibodies against NKG2A

Details for Australian Patent Application No. 2005321017 (hide)

Owner Innate Pharma S.A. Universita di Genova

Inventors Moretta, Alessandro; Marcenaro, Emanuela; Romagne, Francois; Andre, Pascale

Agent Pizzeys

Pub. Number AU-B-2005321017

PCT Pub. Number WO2006/070286

Priority 60/639,465 28.12.04 US; 60/639,832 28.12.04 US

Filing date 27 December 2005

Wipo publication date 6 July 2006

Acceptance publication date 24 February 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

9 August 2007 PCT application entered the National Phase

  PCT publication WO2006/070286 Priority application(s): WO2006/070286

24 February 2011 Application Accepted

  Published as AU-B-2005321017

23 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005321021-Agents and methods for early diagnosis and monitoring of Alzheimer's disease and other neurological disorders

2005321015-Pyrrolidyl derivatives of heteroaromatic compounds as phosphodiesterase inhibitors